Interpace Diagnostics to Present at NobleCon14 on January 29
January 25, 2018 08:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J. , Jan. 25, 2018 (GLOBE NEWSWIRE) -- INTERPACE DIAGNOSTICS GROUP, INC.(NASDAQ:IDXG), a fully integrated commercial and bioinformatics company that provides clinically useful...
Interpace Diagnostics Recognized as One of the Top 20 Bioinformatics Solutions Providers
January 08, 2018 08:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Announces Agreement with ARUP Laboratories
December 18, 2017 08:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces New York State Approval of New Product
November 16, 2017 08:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Corp. (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and...
Interpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
November 13, 2017 08:00 ET
|
Interpace Diagnostics Group, Inc.
Q3-2017 Net Revenues of Over $4 Million Growing 27% Over Prior Year Quarter Represents Fourth Straight Quarter of Sequential Revenue GrowthNet Loss for the Quarter & Year to Date a 56% and 51%...
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017
November 09, 2017 07:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Designated as “Company of the Month” by G2 Intelligence
October 25, 2017 09:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of Gastroenterology (ACG) 2017
October 23, 2017 08:45 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and...
Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®
October 18, 2017 08:45 ET
|
Interpace Diagnostics Group, Inc.
VICTORIA, British Columbia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides...
Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference
October 17, 2017 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) today announced that Jack Stover, the Company’s President and CEO is scheduled to present on...